What You Need to Know about Stem Cell Tourism

In this panel discussion held at NYSCF headquarters, members of the John Hopkins University Berman Institute of Bioethics, patient advocates, and scientists will engage in a discussion exploring the ethics and decision-making of stem cell treatments around the world. What rights should terminally ill and desperate patients have to try experimental treatments? Who gets to decide and what is the path forward? This conversation is part of NYSCF’s Science & Society series.

Featured speakers:
David Carmel, MBA
Head of Immunotherapy, Atara Biotherapeutics

Francesco Clark
SVP, Glansaol; President & CEO, Clark’s Botanicals

Jeffrey Kahn, PhD, MPH
Andreas C. Dracopoulos Director, Johns Hopkins Berman Institute of Bioethics

Susan L. Solomon, JD
CEO & Co-Founder, NYSCF